119 related articles for article (PubMed ID: 15862999)
21. Identification of C10 nitrogen-containing aporphines with dopamine D
Karki A; Juarez R; Namballa HK; Alberts I; Harding WW
Bioorg Med Chem Lett; 2020 Apr; 30(8):127053. PubMed ID: 32107165
[TBL] [Abstract][Full Text] [Related]
22. N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.
Herm L; Berényi S; Vonk A; Rinken A; Sipos A
Bioorg Med Chem; 2009 Jul; 17(13):4756-62. PubMed ID: 19454369
[TBL] [Abstract][Full Text] [Related]
23. N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.
Liu Z; Chen X; Sun P; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Sep; 16(18):8335-8. PubMed ID: 18783955
[TBL] [Abstract][Full Text] [Related]
24. N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands.
Saur O; Hackling AE; Perachon S; Schwartz JC; Sokoloff P; Stark H
Arch Pharm (Weinheim); 2007 Apr; 340(4):178-84. PubMed ID: 17405129
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
27. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
Wu J; Dougherty JJ; Nichols RA
J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
[TBL] [Abstract][Full Text] [Related]
28. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
Schmidt HD; Pierce RC
Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part I: Influence of the substitution on the basic nitrogen and the position of the amide on the affinity for D2L, D4.2, and 5-HT2A receptors.
Carato P; Graulich A; Jensen N; Roth BL; Liégeois JF
Bioorg Med Chem Lett; 2007 Mar; 17(6):1565-9. PubMed ID: 17254782
[TBL] [Abstract][Full Text] [Related]
30. Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.
Seeman P
Synapse; 2007 Dec; 61(12):1013-8. PubMed ID: 17853435
[TBL] [Abstract][Full Text] [Related]
31. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
Ivorra MD; Valiente M; Martínez S; Madrero Y; Noguera MA; Cassels BK; Sobarzo EM; D'Ocon P
Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
[TBL] [Abstract][Full Text] [Related]
32. Amphetamine-induced changes in dopamine receptors in early postnatal rat brain.
Mukda S; Kaewsuk S; Ebadi M; Govitrapong P
Dev Neurosci; 2009; 31(3):193-201. PubMed ID: 19145071
[TBL] [Abstract][Full Text] [Related]
33. Halogenated derivatives of boldine with high selectivity for alpha1A-adrenoceptors in rat cerebral cortex.
Martinez S; Madrero Y; Elorriaga M; Noguera MA; Cassels B; Sobarzo E; D'Ocon P; Ivorra MD
Life Sci; 1999; 64(14):1205-14. PubMed ID: 10210263
[TBL] [Abstract][Full Text] [Related]
34. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
[TBL] [Abstract][Full Text] [Related]
35. Photostability and photoprotection factor of boldine and glaucine.
Hidalgo ME; Farah M; Carrasco L; Fernández E
J Photochem Photobiol B; 2005 Jul; 80(1):65-9. PubMed ID: 15963438
[TBL] [Abstract][Full Text] [Related]
36. In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors.
Stark D; Piel M; Hübner H; Gmeiner P; Gründer G; Rösch F
Bioorg Med Chem; 2007 Nov; 15(21):6819-29. PubMed ID: 17765546
[TBL] [Abstract][Full Text] [Related]
37. Presynaptic D1 dopamine receptors facilitate glutamatergic neurotransmission in the rat globus pallidus.
Hernández A; Sierra A; Valdiosera R; Florán B; Erlij D; Aceves J
Neurosci Lett; 2007 Oct; 425(3):188-91. PubMed ID: 17845833
[TBL] [Abstract][Full Text] [Related]
38. Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
Fitch RW; Kaneko Y; Klaperski P; Daly JW; Seitz G; Gündisch D
Bioorg Med Chem Lett; 2005 Feb; 15(4):1221-4. PubMed ID: 15686946
[TBL] [Abstract][Full Text] [Related]
39. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
[TBL] [Abstract][Full Text] [Related]
40. Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors.
Ibañez-Sandoval O; Hernández A; Florán B; Galarraga E; Tapia D; Valdiosera R; Erlij D; Aceves J; Bargas J
J Neurophysiol; 2006 Mar; 95(3):1800-11. PubMed ID: 16306171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
